While I have no quibbles on the fundamental performance, the valuation looks priced for perfection. I reiterate my sell ...

Opendoor stock achieved meme-stock status and posted massive gains in 2025. The company's sales are declining, and efficiency improvements may not be enough to make the stock a long-term winner. 10 ...

Shares of the pharmaceutical giant trade at less than 9 times its future earnings. Investors are likely concerned about upcoming patent cliffs that may weigh down its financials. However, the company ...